PPARGC1A and metabolic dysfunction-associated steatotic liver disease: In NAFLD, mitochondrial biogenesis, which is regulated by PGC1α, is strongly suppressed, resulting in reduced mitochondrial oxidative phosphorylation (OXPHOS), mitochondrial respiration, and β-oxidation (5, 6), thus enhancing fat accumulation and driving disease progression.